Literature DB >> 2991556

Transformation by Epstein-Barr virus requires DNA sequences in the region of BamHI fragments Y and H.

J Skare, J Farley, J L Strominger, K O Fresen, M S Cho, H zur Hausen.   

Abstract

Eight independent recombinant Epstein-Barr virus genomes, each of which was a transforming strain, were made by superinfecting cell lines containing Epstein-Barr virus DNA (Raji or B95-8 strain) with a nontransforming virus (P3HR1 strain). A knowledge of the constitution of each transforming recombinant allowed the localization of the defect in the genome of the nontransforming parent to a 12-megadalton sequence within the EcoRI A fragment. Within this region, the nontransforming virus has a deletion of the BamHI Y fragment and about half of the sequences in the adjacent BamHI H fragment. The present data suggest that this deletion is responsible for the nontransforming phenotype. Furthermore, mapping a deletion in one of the recombinant genomes allowed the conclusion that a sequence (comprising about 20% of the Epstein-Barr virus genome) from the center of BamHI-D to BamHI-I' is not necessary for the maintenance of transformation by Epstein-Barr virus.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2991556      PMCID: PMC254932     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  27 in total

1.  Epstein-Barr virus RNA. VIII. Viral RNA in permissively infected B95-8 cells.

Authors:  M Hummel; E Kieff
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

2.  RNA encoded by the IR1-U2 region of Epstein-Barr virus DNA in latently infected, growth-transformed cells.

Authors:  V van Santen; A Cheung; M Hummel; E Kieff
Journal:  J Virol       Date:  1983-05       Impact factor: 5.103

3.  Analysis of restriction endonuclease fragments of intracellular Epstein-Barr virus DNA and isoenzymes indicate a common origin of the Raji, NC-37, and F-265 human lymphoid cell lines.

Authors:  L Rymo; T Lindahl; S Povey; G Klein
Journal:  Virology       Date:  1981-11       Impact factor: 3.616

4.  Molecular cloning of the complete Epstein-Barr virus genome as a set of overlapping restriction endonuclease fragments.

Authors:  J R Arrand; L Rymo; J E Walsh; E Björck; T Lindahl; B E Griffin
Journal:  Nucleic Acids Res       Date:  1981-07-10       Impact factor: 16.971

5.  The B95-8 isolate of Epstein-Barr virus arose from an isolate with a standard genome.

Authors:  J Skare; C Edson; J Farley; J L Strominger
Journal:  J Virol       Date:  1982-12       Impact factor: 5.103

6.  Organization of the Epstein-Barr virus DNA molecule. II. Fine mapping of the boundaries of the internal repeat cluster of B95-8 and identification of additional small tandem repeats adjacent to the HR-1 deletion.

Authors:  S D Hayward; S G Lazarowitz; G S Hayward
Journal:  J Virol       Date:  1982-07       Impact factor: 5.103

7.  Deletion of the nontransforming Epstein-Barr virus strain P3HR-1 causes fusion of the large internal repeat to the DSL region.

Authors:  G W Bornkamm; J Hudewentz; U K Freese; U Zimber
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

8.  Epstein-Barr virus DNA XII. A variable region of the Epstein-Barr virus genome is included in the P3HR-1 deletion.

Authors:  W King; T Dambaugh; M Heller; J Dowling; E Kieff
Journal:  J Virol       Date:  1982-09       Impact factor: 5.103

9.  Stable expression in mouse cells of nuclear neoantigen after transfer of a 3.4-megadalton cloned fragment of Epstein-Barr virus DNA.

Authors:  W P Summers; E A Grogan; D Shedd; M Robert; C R Liu; G Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

10.  Non-immortalizing P3J-HR-1 Epstein-Barr virus: a deletion mutant of its transforming parent, Jijoye.

Authors:  M Rabson; L Gradoville; L Heston; G Miller
Journal:  J Virol       Date:  1982-12       Impact factor: 5.103

View more
  44 in total

1.  Infection of primary human monocytes by Epstein-Barr virus.

Authors:  M Savard; C Bélanger; M Tardif; P Gourde; L Flamand; J Gosselin
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation.

Authors:  J I Cohen; F Wang; J Mannick; E Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

3.  Characterization of the deletion and rearrangement in the BamHI C region of the X50-7 Epstein-Barr virus genome, a mutant viral strain which exhibits constitutive BamHI W promoter activity.

Authors:  C N Yandava; S H Speck
Journal:  J Virol       Date:  1992-09       Impact factor: 5.103

4.  Biophysical and mutational analysis of the putative bZIP domain of Epstein-Barr virus EBNA 3C.

Authors:  Michelle J West; Helen M Webb; Alison J Sinclair; Derek N Woolfson
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

5.  BHRF1, the Epstein-Barr virus gene with homology to Bc12, is dispensable for B-lymphocyte transformation and virus replication.

Authors:  A Marchini; B Tomkinson; J I Cohen; E Kieff
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

6.  EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus.

Authors:  N S Sung; S Kenney; D Gutsch; J S Pagano
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

Review 7.  Theodore E. Woodward Award: development of novel, EBV-targeted therapies for EBV-positive tumors.

Authors:  Shannon Kenney
Journal:  Trans Am Clin Climatol Assoc       Date:  2006

8.  The evolution of Epstein-Barr virus inferred from the conservation and mutation of the virus glycoprotein gp350/220 gene.

Authors:  Asako Kawaguchi; Kyosuke Kanai; Yukio Satoh; Chizu Touge; Keiko Nagata; Takeshi Sairenji; Yoshitsugu Inoue
Journal:  Virus Genes       Date:  2009-01-20       Impact factor: 2.332

9.  Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1.

Authors:  F Wang; S F Tsang; M G Kurilla; J I Cohen; E Kieff
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

10.  Epstein-Barr virus (EBV) recombinants: use of positive selection markers to rescue mutants in EBV-negative B-lymphoma cells.

Authors:  F Wang; A Marchini; E Kieff
Journal:  J Virol       Date:  1991-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.